Sharp corners of castleman diseaseclinical case
DOI:
https://doi.org/10.52692/1857-0011.2024.1-78.25Keywords:
Castleman disease, diagnosis, immunohistochemical researchAbstract
Castleman’s disease (CD) is a very rare condition that can occur at any age and affects 16:100000 patients/years. CD is characterized by systemic inflammatory symptoms, generalized lymphadenopathy, polyclonal lymphocyte proliferation and multiple organ system dysfunctions, often associated with autoimmune manifestations, which may precede diagnosis, may be identified concurrently or may follow diagnosis. The given article presents the major and minor criteria on the basis of which the diagnosis is established, as well as the importance of interdisciplinary work in identifying and making the differential diagnosis of the Castleman disease.
References
Fajgenbaum DC, Uldrick TS, Bagg A et al. International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease. Blood, 2017;129:1646–57.
Zhou T, Wang HW, Pittaluga S, Jaffe ES. Multicentric Castleman disease and the evolution of the concept. Pathologica, 2021;113:339–53.
Sun DP, Chen WM, Wang L et al. Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases. Cancer Res. Clin. Oncol., 2021;147:2107–15.
Muskardin TW, Peterson BA, Molitor JA. Castleman disease and associated autoimmune disease. Curr. Opin. Rheumatol., 2012;24:76–83
Szalat R, Munshi NC. Diagnosis of Castleman disease. Hematol. Oncol. Clin. North. Am., 2018;32:53–64.
Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood, 2020;135:1353–64.
Simpson D. Epidemiology of Castleman Disease. Hematol. Oncol. Clin. North. Am., 2018 Feb;32(1):1-10.
Robinson D, Reynolds M. et al. Clinical epidemiology and treatment patterns of patients with multicentric Castleman disease: results from two US treatment centres. Haematol., 2014 Apr;165(1):39-48
Shahidi H, Myers JL, Kvale PA. Castleman’s disease. Mayo Clin. Proc.,1995 Oct;70(10):969-77.
Wu D, Lim MS, Jaffe ES. Patologia bolii Castleman. Hematol. Onco. Clin. North Am., Februarie 2018; 32 (1): 37-52
Dispenzieri A, Gertz MA. Tratamentul bolii Castleman. Curr. Treat. Options Oncol., 2005; 6 (3): 255-66.1
Andrés González García, et al. Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis, Rheumatology, vol. 62, Issue 4, 2023, p. 1426– 1435, https://doi.org/10.1093/rheumatology/keac481.
Downloads
Published
License
Copyright (c) 2024 Bulletin of the Academy of Sciences of Moldova. Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
